Cidal and subcidal effect of triethylene thiophosphoramide on cell kinetics of human bladder carcinoma cells in vitro
- PMID: 405754
- DOI: 10.1620/tjem.121.391
Cidal and subcidal effect of triethylene thiophosphoramide on cell kinetics of human bladder carcinoma cells in vitro
Abstract
In view of increasing topical use of various chemotherapeutic agents for bladder carcinoma, an experimental study concerning the effect of triethylene thiophosphoramide (Thio-Tepa) on cell kinetics of bladder carcinoma cells was performed, working on an established cell line of human bladder carcinoma. This polyfunctional alkylating agent, which is most widely used for instillation chemotherapy of bladder carcinoma, revealed a concentration dependent cytotoxicity against the cells. DNA precursor incorporation suggested that repair mechanism occurred following subcidal dose of this compound and faulty repair took place following cidal dose. The cell cycle was prolonged after subcidal treatment, the main effect being seen in DNA synthetic phase, and the changes in the cell cycle parameters returned to the normal within 2 cell cycle time. Repeated treatment with subcidal dose at an interval of 48 hr led to more extensive changes in the cell cycle as compared with that of single dose. Repeated exposures to subcidal dose, however, did not show any differences in the growth curves from those of the controls.
Similar articles
-
Changes of cell cycle affecting cidal effect of triethylene thiophosphoramide on cultured human bladder carcinoma cells.Tohoku J Exp Med. 1978 Jun;125(2):163-7. doi: 10.1620/tjem.125.163. Tohoku J Exp Med. 1978. PMID: 99842
-
[Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].Nihon Hinyokika Gakkai Zasshi. 1977 Nov;68(11):1029-35. Nihon Hinyokika Gakkai Zasshi. 1977. PMID: 415167 Japanese. No abstract available.
-
Cellular pharmacology of N,N',N''-triethylene thiophosphoramide.Cancer Lett. 1988 Aug 15;41(2):157-68. doi: 10.1016/0304-3835(88)90112-7. Cancer Lett. 1988. PMID: 3135933
-
[Enhanced cell killing by thio-TEPA and urokinase (author's transl)].Nihon Hinyokika Gakkai Zasshi. 1979 Jan;70(1):15-27. doi: 10.5980/jpnjurol1928.70.1_15. Nihon Hinyokika Gakkai Zasshi. 1979. PMID: 107356 Japanese. No abstract available.
-
The biology and treatment of superficial bladder cancer.J Clin Oncol. 1984 May;2(5):505-31. doi: 10.1200/JCO.1984.2.5.505. J Clin Oncol. 1984. PMID: 6427417 Review.
Cited by
-
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.Cancer Chemother Pharmacol. 1987;19(2):143-8. doi: 10.1007/BF00254567. Cancer Chemother Pharmacol. 1987. PMID: 3105905
MeSH terms
Substances
LinkOut - more resources
Full Text Sources